Roswell Park Studies Highlight Emerging Treatment Options for Neuroendocrine Tumors
July 15, 2020
July 15, 2020
BUFFALO, New York, July 15 -- The Roswell Park Comprehensive Cancer Center issued the following news release:
Two new studies led by Renuka Iyer, MD, Section Chief for Gastrointestinal Oncology at Roswell Park Comprehensive Cancer Center, highlight possible new treatment options for patients with neuroendocrine tumors (NETs) -- a rare and hard-to-treat cancer.
The first publication focuses on a cancer immunotherapy developed by two of her Roswell Park colleagues that ha . . .
Two new studies led by Renuka Iyer, MD, Section Chief for Gastrointestinal Oncology at Roswell Park Comprehensive Cancer Center, highlight possible new treatment options for patients with neuroendocrine tumors (NETs) -- a rare and hard-to-treat cancer.
The first publication focuses on a cancer immunotherapy developed by two of her Roswell Park colleagues that ha . . .